News
Elon Musk’s Neuralink has recently achieved a significant milestone with its experimental vision-restoring implant, Blindsight. The U.S. Food and Drug Administration (FDA) has granted the device ...
The Tesla CEO said that Neuralink, another one of his tech companies, planned on implanting its new brain chip, Blindsight, into a human patient for the first time in late 2025. Newsweek contacted ...
Neuralink says the Food and Drug Administration has designated its experimental Blindsight implant as a "breakthrough device." The company is developing the technology in an attempt to restore ...
Neuralink’s Blindsight, the latest recipient, is a new iteration of a technology that has been used for decades to experimentally restore very limited vision to certain blind people. A ...
Neuralink, a neurotechnology company founded by Mr. Musk, announced in a statement on X that it had “received Breakthrough Device Designation from the FDA” for its Blindsight device. “The Blindsight ...
Neuralink's Blindsight implant aims to restore vision for individuals with complete blindness by bypassing damaged optic nerves and directly interfacing with the brain. Neuralink’s Blindsight ...
Elon Musk recently pronounced that the next Neuralink project will be a “Blindsight” cortical implant to restore vision: “Resolution will be low at first, like early Nintendo graphics ...
Back in March, Musk used his X platform to announce the progress that was being made in developing Blindsight, a cortical implant that aims to not just restore vision but provide 'high-resolution ...
Neuralink has proven its electronics to brain connection device and now has FDA approval for a Blindsight device. It would be a real life version of the Geordie Laforge’s visor in Star Trek the Next ...
Neuralink recently announced that it has received "Breakthrough Device Designation" from the FDA for Blindsight, a device designed to restore vision to those who can no longer see. According to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results